Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 2
1989 4
1990 3
1991 3
1992 2
1993 1
1994 4
1995 1
1996 9
1997 5
1998 14
1999 10
2000 11
2001 10
2002 26
2003 30
2004 42
2005 28
2006 30
2007 35
2008 47
2009 52
2010 51
2011 55
2012 39
2013 55
2014 53
2015 41
2016 39
2017 25
2018 25
2019 20
2020 22
2021 18
2022 22
2023 18
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

796 results

Results by year

Filters applied: . Clear all
Page 1
Milnacipran.
[No authors listed] [No authors listed] 2019 May 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2019 May 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643293 Free Books & Documents. Review.
Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders. Levomilnacipran is an enantiomer of milnacipran, which is used to treat fibromyalgia. Levomilnacipran and milnacipran have been associated with a low rate …
Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders. Levomilnacipran is an enantio …
Milnacipran for the Treatment of Fibromyalgia.
Gupta H, Girma B, Jenkins JS, Kaufman SE, Lee CA, Kaye AD. Gupta H, et al. Health Psychol Res. 2021 Jul 10;9(1):25532. doi: 10.52965/001c.25532. eCollection 2021. Health Psychol Res. 2021. PMID: 34746490 Free PMC article. Review.
PURPOSE OF REVIEW: This is a comprehensive review of the literature regarding the use of milnacipran in treating fibromyalgia. A chronic pain disorder with other system disturbances, fibromyalgia is often resistant to many therapeutic approaches. ...A variety of therapeuti …
PURPOSE OF REVIEW: This is a comprehensive review of the literature regarding the use of milnacipran in treating fibromyalgia. A chro …
Milnacipran.
[No authors listed] [No authors listed] 2024 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000659 Free Books & Documents. Review.
Amounts of milnacipran in breastmilk are low and would not be expected to cause any adverse effects in breastfed infants. However, until more data become available, milnacipran should be used with caution during breastfeeding, especially while nursing a newborn or p …
Amounts of milnacipran in breastmilk are low and would not be expected to cause any adverse effects in breastfed infants. However, un …
Milnacipran hydrochloride.
[No authors listed] [No authors listed] Aust Prescr. 2017 Dec;40(6):244-245. doi: 10.18773/austprescr.2017.078. Epub 2017 Oct 23. Aust Prescr. 2017. PMID: 29375190 Free PMC article. Review. No abstract available.
Gut microbe-derived milnacipran enhances tolerance to gut ischemia/reperfusion injury.
Deng F, Hu JJ, Lin ZB, Sun QS, Min Y, Zhao BC, Huang ZB, Zhang WJ, Huang WK, Liu WF, Li C, Liu KX. Deng F, et al. Cell Rep Med. 2023 Mar 21;4(3):100979. doi: 10.1016/j.xcrm.2023.100979. Cell Rep Med. 2023. PMID: 36948152 Free PMC article.
Here, we show that mice exhibit significant differences in susceptibility to I/R-induced enterogenic sepsis. Notably, the milnacipran (MC) content in the enterogenic-sepsis-tolerant mice is significantly higher. ...
Here, we show that mice exhibit significant differences in susceptibility to I/R-induced enterogenic sepsis. Notably, the milnacipran …
Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.
Keks NA, Hope J, Keogh S, Copolov DL. Keks NA, et al. Australas Psychiatry. 2018 Oct;26(5):537-540. doi: 10.1177/1039856218794874. Epub 2018 Sep 10. Australas Psychiatry. 2018. PMID: 30198305 Review.
This paper will briefly review milnacipran and its utility in psychiatry for the treatment of depression. ...Milnacipran helps a minority of patients with fibromyalgia by reducing pain and fatigue. ...
This paper will briefly review milnacipran and its utility in psychiatry for the treatment of depression. ...Milnacipran helps …
Milnacipran for neuropathic pain in adults.
Derry S, Phillips T, Moore RA, Wiffen PJ. Derry S, et al. Cochrane Database Syst Rev. 2015 Jul 6;2015(7):CD011789. doi: 10.1002/14651858.CD011789. Cochrane Database Syst Rev. 2015. PMID: 26148202 Free PMC article. Review.
BACKGROUND: Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) that is sometimes used to treat chronic neuropathic pain and fibromyalgia. ...AUTHORS' CONCLUSIONS: There was no evidence to support the use of milnacipran to treat neuropathic pain cond …
BACKGROUND: Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) that is sometimes used to treat chronic neuropathic p …
Milnacipran: beyond a role of antidepressant.
Pae CU, Marks DM, Shah M, Han C, Ham BJ, Patkar AA, Masand PS. Pae CU, et al. Clin Neuropharmacol. 2009 Nov-Dec;32(6):355-63. doi: 10.1097/WNF.0b013e3181ac155b. Clin Neuropharmacol. 2009. PMID: 19620845 Review.
Milnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) with negligible effects on any presynaptic or postsynaptic receptors. ...The half-life of milnacipran is approximately 8 hours. In addition, milnacipran does not inhibit the cytochrome P …
Milnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) with negligible effects on any presynaptic or postsynaptic re …
Milnacipran for pain in fibromyalgia in adults.
Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ. Cording M, et al. Cochrane Database Syst Rev. 2015 Oct 20;2015(10):CD008244. doi: 10.1002/14651858.CD008244.pub3. Cochrane Database Syst Rev. 2015. PMID: 26482422 Free PMC article. Review.
That review considered both fibromyalgia and neuropathic pain, but the efficacy of milnacipran for neuropathic pain is now dealt with in a separate review.Milnacipran is a serotonin-norepinephrine (noradrenaline) reuptake inhibitor (SNRI) that is licensed for the tr …
That review considered both fibromyalgia and neuropathic pain, but the efficacy of milnacipran for neuropathic pain is now dealt with …
Milnacipran. A review of its use in depression.
Spencer CM, Wilde MI. Spencer CM, et al. Drugs. 1998 Sep;56(3):405-27. doi: 10.2165/00003495-199856030-00010. Drugs. 1998. PMID: 9777315 Review.
However, when doses are titrated (not a requirement for milnacipran), milnacipran 50 or 100 mg/day has a slower onset than the tricyclic antidepressant. ...In a 6-month trial, milnacipran was less effective than clomipramine. Milnacipran 50 or 100 mg t …
However, when doses are titrated (not a requirement for milnacipran), milnacipran 50 or 100 mg/day has a slower onset than the …
796 results